This inventor holds 1 USPTO granted patent. Top assignees: Pliva Handels Gmbh, Pliva, Inc.. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 3 Years Active: 1994
Title: Miljenko Dumic: Innovator in Pharmaceutical Chemistry
Introduction
Miljenko Dumic is a notable inventor based in Zagreb, YU. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patent work. His research has led to the development of valuable compounds that have potential applications in medicine.
Latest Patents
Miljenko Dumic holds a patent for N-sulfonyl-tetrahydro-[1,3]-dioxepino[5,6-b]azirines. This invention involves the synthesis of novel hypoglycaemically active compounds starting from cis-2-butene-1,4-diol. The process includes the use of intermediates such as 4,7-dihydro-1,3-dioxepin and trans-6-acylamino-5-chloro-1,3-dioxepans. These inventive compounds serve as valuable intermediates in the synthesis of other biologically active substances.
Career Highlights
Throughout his career, Miljenko Dumic has worked with prominent companies in the pharmaceutical industry, including Pliva Handels GmbH and Pliva, Inc. His work has been instrumental in advancing the development of new therapeutic agents.
Collaborations
Miljenko has collaborated with notable colleagues such as Darko Filic and Mladen Vinkovi. Their combined expertise has contributed to the success of various projects in the field of pharmaceutical research.
Conclusion
Miljenko Dumic's innovative work in the synthesis of biologically active compounds highlights his significant role in pharmaceutical chemistry. His contributions continue to influence the development of new therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile